Carfilzomib, Bendamustine Hydrochloride, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
Clinical trial NCT02095834 · COMPLETED
Trial details
- NCT number
- NCT02095834
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-04-24
- Primary completion
- 2021-01-07
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.